Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
about
The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse Model.Deciphering the epidemiology of hepatocellular carcinoma through the passage of time: A study of 1,401 patients across 3 decades.Paracentesis in cirrhotics is associated with increased risk of 30-day readmission.Quantitative screening of serum protein biomarkers by reverse phase protein arrays
P2860
Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Mortality assessment of patien ...... sease and treatment modalities
@en
type
label
Mortality assessment of patien ...... sease and treatment modalities
@en
prefLabel
Mortality assessment of patien ...... sease and treatment modalities
@en
P2093
P2860
P1433
P1476
Mortality assessment of patien ...... sease and treatment modalities
@en
P2093
Cameron T Locklear
Mehmet Sayiner
Munkhzul Otgonsuren
Pegah Golabi
Sofie Fazel
Zobair M Younossi
P2860
P356
10.1097/MD.0000000000005904
P407
P577
2017-03-01T00:00:00Z